Categories: HealthcareLifestyle

US FDA seeks to allow salt substitutes in everyday foods

The U.S. Food and Drug Administration (FDA) on Friday said it was proposing a rule to allow the use of salt substitutes in everyday foods including cheese, frozen peas and canned tuna, in a bid to cut Americans’ salt consumption.

The FDA had in 2021 set a new voluntary goal for manufacturers and chain restaurants to cut salt levels by an average of 12% in packaged foods, because excessive salt consumption has been linked to high blood pressure, a leading cause of heart attack and stroke.

“Most people in the U.S. consume too much sodium. The majority of sodium consumed comes from processed, packaged and prepared foods, not from salt people add to their food when cooking or eating,” said Susan Mayne, the director of FDA’s food safety and nutrition division.

Friday’s proposed rule looks to change the FDA’s “standards of identity” (SOI) for over 20 items, ranging from cheese to cereal flour.

The SOIs list ingredients that standardized foods must contain, and which ingredients are optional.

Source : Reuters

GLOBAL BUSINESS AND FINANCE MAGAZINE

Recent Posts

IMF strategy chief urges countries to maintain price stability

Christian Mumssen, the fund's new director of ​strategy, cited a rapid succession of major shocks…

3 days ago

Gold bounces from two-week low, markets await US inflation data

Gold bounces from two-week low, markets await US inflation data. Gold ticked higher on Tuesday…

3 days ago

Dollar dips ahead of US inflation data, supported by rate outlook

Reuters poll forecasts U.S. headline inflation at 3.8%.  The dollar remained in sight of 13-month…

3 days ago

After Credit Suisse, markets find bail-in less credible

When Credit Suisse failed in March 2023, Swiss authorities, against market expectations, set aside the…

3 days ago

Higher utilisation explains the recent surge in productivity growth

US labour productivity has accelerated since 2022. Output per hour grew around 2.5% per year…

3 days ago

Harmonising access and reinventing the procurement of innovative medicines in Europe

Europe pays for innovative medicines through 27 uncoordinated national negotiations, generating access delays, cross-country pricing…

3 days ago